Douglas F. Nixon, MD, PhD, director of Northwell Health’s Institute of Translational Research at the Feinstein Institutes for Medical Research, has been named a Fellow of the Infectious Diseases Society of America (IDSA). Dr. Nixon is recognized for his extensive work in immunovirology research over the past three decades.
Dr. Nixon has contributed to multiple areas within the field, including clinical research, human immunology, basic virology and molecular biology. He is known for pioneering studies on human endogenous retroviruses (HERVs), sometimes referred to as “junk DNA” or “dark genome,” which do not code for genes but may play a role in neuroimmunological, neurodevelopmental and neurodegenerative conditions.
At the Institute of Translational Research, Dr. Nixon leads efforts to accelerate treatment development for diseases such as Alzheimer’s disease, cancer, HIV/AIDS and other viral infections as well as mental health disorders.
“I am honored to be elected a Fellow of the Infectious Diseases Society of America. This recognition is a testament to the collaborative spirit and dedication of my colleagues and mentors who have inspired and supported me throughout my career,” said Dr. Nixon. “I am eager to contribute further to the critical mission of the society, advancing research and clinical care in infectious diseases for the benefit of patients worldwide.”
